Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Appendix B: Panel Roster and Financial Disclosures

Bacterial Enteric

Last Updated: April 1, 2016; Last Reviewed: April 1, 2016

Bacterial Enteric Infections
Member Financial Disclosure
Company Relationship
Bowen, Anna Centers for Disease Control and Prevention Procter and Gamble Research Support
Pham, Paul University of Maryland & Westview Urgent Care Medi Center None N/A
Sears, Cynthia* Johns Hopkins University Clinical Infectious Diseases Other
Merieux Institute Research Support
NIH Research Support
Up-To-Date Other
Wanke, Christine Tufts University Medical School GlaxoSmithKline Research Support
Optimer Pharmaceutical DSMB
Pfizer Clinical Trial Even Adjucation
* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from April 1, 2014, through April 1, 2016.

Download Guidelines